Skip to Content

WATSON 408 (Lisinopril 20 mg)

Pill with imprint WATSON 408 is Yellow, Round and has been identified as Lisinopril 20 mg. It is supplied by Watson Pharmaceuticals.

Lisinopril is used in the treatment of high blood pressure; diabetic kidney disease; heart attack; alport syndrome; coronary artery disease (and more), and belongs to the drug class Angiotensin Converting Enzyme Inhibitors. There is positive evidence of human fetal risk during pregnancy. Lisinopril 20 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for WATSON 408

Lisinopril

Imprint:
WATSON 408
Strength:
20 mg
Color:
Yellow
Shape:
Round
Availability:
Prescription only
Drug Class:
Angiotensin Converting Enzyme Inhibitors
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Watson Pharmaceuticals
Inactive Ingredients:
silicon dioxide
calcium phosphate dihydrate dibasic
magnesium stearate
mannitol
corn starch
FD&C Yellow No. 5
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC CodeLabeler / Repackager
63739-0350 McKesson Packaging Services
43063-0007 PDRX Pharmaceuticals Inc. (repackager)

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide